← All stocks

Aura Biosciences, Inc.

AURA Net selling
CIK 0001501796 #2744 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$40.06M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$40.06M
14 of 14 sales
Net
−$40.06M
−$40.06M against sales at will

By person

17 insiders · 14 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Matrix Capital Management Company, LP entity
10% owner
$39.04M (1)
−$39.04M
0
$0.00
−100.0%
de los Pinos Elisabet
See Remarks
$380.83K (3)
−$380.83K
575,815
$3.70M
+75.5%
Hopkins Janet Jill
Chief Medical Officer
$195.96K (2)
−$195.96K
380,190
$2.44M
+132.5%
Plavsic Mark
Chief Technology Officer
$157.52K (2)
−$157.52K
243,736
$1.56M
+89.7%
Kilroy Conor
See Remarks
$143.40K (2)
−$143.40K
232,693
$1.49M
+142.4%
Gibney Anthony S
See Remarks
$82.33K (1)
−$82.33K
265,354
$1.70M
+3,040%
Elazzouzi Amy
SVP, Finance & PAO
$56.63K (3)
−$56.63K
143,600
$921.91K
+259.0%
Holles Natalie C.
See Remarks
1,153,962
$7.41M
Johnson David Michael
Director
194,167
$1.25M
+32.8%
Abu-Absi Susan
Chief Operating Officer
134,513
$863.57K
Feder Julie B
Chief Financial Officer
134,276
$862.05K
0.0%
Person Julie
Chief People Officer
107,611
$690.86K
Kratz Erica
Chief Reg. & Quality Officer
100,885
$647.68K
Srivastava Sapna
Director
38,500
$247.17K
+266.7%
Mattessich Antony C.
Director
38,500
$247.17K
+266.7%
Bitetti Teresa Marie
Director
36,000
$231.12K
Bender Jeremy
Director
30,000
$192.60K

No percentages here. This company's share count has moved by a factor of 2.1 over the window, from 49,951,466 to 103,704,809 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Gibney Anthony S
16 Jun 2026
See Remarks
Sell
12,824
$6.42
$82.33K
Matrix Capital Management Company, LP
7 May 2026
10% owner
Sell indirect
6,922,870
$5.64
$39.04M
Kilroy Conor
16 Apr 2026
See Remarks
Sell
11,738
$7.02
$82.40K
de los Pinos Elisabet
17 Feb 2026
See Remarks
Sell
47,648
$5.06
$241.10K
Elazzouzi Amy
17 Feb 2026
Senior Vice President, Finance
Sell
8,549
$5.06
$43.26K
Hopkins Janet Jill
17 Feb 2026
Chief Medical Officer
Sell
20,401
$5.06
$103.23K
Plavsic Mark
17 Feb 2026
Chief Technology Officer
Sell
15,890
$5.05
$80.24K
Kilroy Conor
17 Feb 2026
See Remarks
Sell
12,079
$5.05
$61.00K
de los Pinos Elisabet
20 Jan 2026
See Remarks
Sell
16,928
$4.86
$82.27K
Elazzouzi Amy
20 Jan 2026
Senior Vice President, Finance
Sell
1,581
$4.86
$7.68K
Hopkins Janet Jill
17 Nov 2025
Chief Medical Officer
Sell
17,109
$5.42
$92.73K
de los Pinos Elisabet
29 Oct 2025
See Remarks
Sell
9,049
$6.35
$57.46K
Elazzouzi Amy
29 Oct 2025
Senior Vice President, Finance
Sell
896
$6.35
$5.69K
Plavsic Mark
16 Oct 2025
Chief Technology Officer
Sell
12,169
$6.35
$77.27K

What was left out

Form 4 filings counted 32
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 14
Transactions with no price 0
Shares from compensation/vesting 2,179,726
History held since 29 Oct 2021